Emergent BioSolutions (NYSE:EBS) has signed an agreement with AstraZeneca (NYSE:AZN) to provide contract development and manufacturing (CDMO) services for large-scale drug substance manufacturing for AZN's COVID-19 vaccine candidate, AZD1222.
SUBSCRIBE
Biohealth Innovation
Founding Member of
